Healthcare provider profile · identity verified

Paul Andrew Midkiff, MD

Family Practice · ASHEVILLE, NC · NPI 1417996331

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	565	154
Lisinopril	Lisinopril	382	101
Levothyroxine Sodium	Levothyroxine Sodium	334	79
Amlodipine Besylate	Amlodipine Besylate	311	87
Rosuvastatin Calcium	Rosuvastatin Calcium	248	69
Gabapentin	Gabapentin	228	64
Omeprazole	Omeprazole	227	67
Losartan Potassium	Losartan Potassium	191	55
Metoprolol Succinate	Metoprolol Succinate	179	46
Tramadol Hcl	Tramadol Hcl	170	43
Sertraline Hcl	Sertraline Hcl	158	37
Trazodone Hcl	Trazodone Hcl	146	42
Furosemide	Furosemide	142	41
Pantoprazole Sodium	Pantoprazole Sodium	140	39
Potassium Chloride	Potassium Chloride	129	35
Allopurinol	Allopurinol	124	32
Lorazepam	Lorazepam	122	31
Tamsulosin Hcl	Tamsulosin Hcl	108	33
Alprazolam	Alprazolam	106	16
Venlafaxine Hcl Er	Venlafaxine Hcl	97	22
Metformin Hcl	Metformin Hcl	94	28
Hydrochlorothiazide	Hydrochlorothiazide	89	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	86	24
Jardiance	Empagliflozin	86	18
Metoprolol Tartrate	Metoprolol Tartrate	86	28
Albuterol Sulfate Hfa	Albuterol Sulfate	85	35
Fluticasone Propionate	Fluticasone Propionate	84	28
Metformin Hcl Er	Metformin Hcl	84	23
Zolpidem Tartrate	Zolpidem Tartrate	83	22
Buspirone Hcl	Buspirone Hcl	77	26
Prednisone	Prednisone	77	55
Chlorthalidone	Chlorthalidone	74	20
Simvastatin	Simvastatin	71	23
Ozempic	Semaglutide	69	12
Clopidogrel	Clopidogrel Bisulfate	67	13
Eliquis	Apixaban	66	15
Oxycodone Hcl	Oxycodone Hcl	64	suppressed
Famotidine	Famotidine	62	16
Celecoxib	Celecoxib	59	20
Xarelto	Rivaroxaban	57	11
Cephalexin	Cephalexin	56	45
Bupropion Xl	Bupropion Hcl	55	14
Carvedilol	Carvedilol	55	13
Citalopram Hbr	Citalopram Hydrobromide	55	20
Escitalopram Oxalate	Escitalopram Oxalate	52	15
Meloxicam	Meloxicam	49	19
Myrbetriq	Mirabegron	48	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	47	suppressed
Duloxetine Hcl	Duloxetine Hcl	45	12
Montelukast Sodium	Montelukast Sodium	45	15
Amitriptyline Hcl	Amitriptyline Hcl	43	14
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Glipizide	Glipizide	41	suppressed
Mirtazapine	Mirtazapine	40	13
Alendronate Sodium	Alendronate Sodium	39	suppressed
Spironolactone	Spironolactone	37	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	37	suppressed
Finasteride	Finasteride	34	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Ondansetron Hcl	Ondansetron Hcl	32	15
Atenolol	Atenolol	31	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	15
Synthroid	Levothyroxine Sodium	29	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	26	26
Clonazepam	Clonazepam	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	24
Glipizide Er	Glipizide	26	suppressed
Torsemide	Torsemide	26	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	25	25
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	22
Triamcinolone Acetonide	Triamcinolone Acetonide	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	21
Ibuprofen	Ibuprofen	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Xtampza Er	Oxycodone Myristate	24	suppressed
Estradiol	Estradiol	23	12
Ketoconazole	Ketoconazole	22	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Amoxicillin	Amoxicillin	21	16
Baclofen	Baclofen	21	suppressed
Nystatin	Nystatin	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Fluconazole	Fluconazole	20	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	20	17
Valsartan	Valsartan	20	suppressed
Telmisartan	Telmisartan	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	11
Benazepril Hcl	Benazepril Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Primidone	Primidone	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	15	15
Azithromycin	Azithromycin	15	13
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Ascomp With Codeine	Codeine/Butalbital/Asa/Caffein	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Colchicine	Colchicine	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Novolog	Insulin Aspart	11	suppressed
Olanzapine	Olanzapine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error